PSG5 and COVID-19: They further explained the cause for the altered expression of PSGs and showed that the dysregulation of enhancers originating from Long Terminal Repeat 8B (LTR8B) may be a pivotal factor in the suppression of PSG expression within the syncytiotrophoblasts of COVID-19 patients.